Oxford Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Oxford Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-185,467	Closed	-$2.58M	–	2033
2019 Q1	$2.58M	Buy	185,467 +27,097	+17%	+$310K	0.06%	458
2018 Q4	$1.73M	Buy	158,370 +26,006	+20%	+$274K	0.04%	548
2018 Q3	$1.67M	Sell	132,364 -155,936	-54%	-$1.88M	0.03%	765
2018 Q2	$3.91M	Buy	288,300 +91,286	+46%	+$1.09M	0.07%	298
2018 Q1	$2.68M	Sell	197,014 -24,778	-11%	-$256K	0.06%	425
2017 Q4	$1.31M	Sell	221,792 -24,577	-10%	-$169K	0.03%	796
2017 Q3	$1.85M	Buy	246,369 +66,910	+37%	+$556K	0.04%	654
2017 Q2	$1.68M	Sell	179,459 -36,222	-17%	-$266K	0.03%	685
2017 Q1	$1.57M	Sell	215,681 -64,466	-23%	-$464K	0.04%	606
2016 Q4	$2.07M	Sell	280,147 -47,242	-14%	-$340K	0.07%	317
2016 Q3	$1.98M	Sell	327,389 -209,132	-39%	-$988K	0.06%	408
2016 Q2	$2.41M	Buy	+536,521	New	+$2.01M	0.08%	331

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Oxford Asset Management's CCXI Position: Q2 2019 in Review

Oxford Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2019, closing a stake of 185,467 shares — an estimated $2.58M sold.

Oxford Asset Management first reported a position in CCXI in Q2 2016 and held it in 12 quarters. The position peaked at $3.91M in Q2 2018. 117 funds tracked by Wall St. Rank hold CCXI as of Q2 2019.

Oxford Asset Management reported no remaining ChemoCentryx, Inc. position as of Q2 2019 after selling out during the quarter.
Oxford Asset Management sold 185,467 ChemoCentryx, Inc. shares in Q2 2019, an estimated $2.58M.
Oxford Asset Management first reported a position in ChemoCentryx, Inc. in Q2 2016 and held it in 12 quarters.
Oxford Asset Management's ChemoCentryx, Inc. position peaked at $3.91M in Q2 2018.
117 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.